Skip to main content
Log in

Bone quality in Duchenne muscular dystrophy

  • Letter
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Code availability

Not applicable.

Availability of data

All data are available from the corresponding author.

References

  1. Catalano A, Vita GL, Bellone F, Sframeli M, Distefano MG, La Rosa M, Gaudio A, Vita G, Morabito N, Messina S (2022) Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates. J Endocrinol Invest 45(3):517–525. https://doi.org/10.1007/s40618-021-01676-4

    Article  CAS  PubMed  Google Scholar 

  2. Finsterer J, Strobl W (2011) Orthopaedic abnormalities in primary myopathies. Acta Orthop Belg 77(5):563–582

    PubMed  Google Scholar 

  3. Ponzetti M, Ucci A, Maurizi A, Giacchi L, Teti A, Rucci N (2022) Lipocalin 2 influences bone and muscle phenotype in the MDX mouse model of Duchenne muscular dystrophy. Int J Mol Sci 23(2):958. https://doi.org/10.3390/ijms23020958

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wada E, Hamano T, Matsui I, Yoshida M, Hayashi YK, Matsuda R (2019) Renal involvement in the pathogenesis of mineral and bone disorder in dystrophin-deficient mdx mouse. J Physiol Sci 69(4):661–671. https://doi.org/10.1007/s12576-019-00683-8

    Article  PubMed  Google Scholar 

Download references

Funding

No funding was received.

Author information

Authors and Affiliations

Authors

Contributions

JF: design, literature search, discussion, first draft, critical comments, final approval, WS: literature search, discussion, critical comments, final approval.

Corresponding author

Correspondence to J. Finsterer.

Ethics declarations

Conflict of interest

None.

Ethics approval

Was in accordance with ethical guidelines. The study was approved by the institutional review board.

Consent to participate

Was obtained from the patient.

Consent for publication

Was obtained from the patient.

Human participants and animals statement

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Finsterer, J., Strobl, W. Bone quality in Duchenne muscular dystrophy. J Endocrinol Invest 45, 1265–1266 (2022). https://doi.org/10.1007/s40618-022-01783-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-022-01783-w

Keywords

Navigation